Qube Research & Technologies LTD Incyte Corp Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Incyte Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 221,755 shares of INCY stock, worth $17.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

221,755

Previous 1,222,629 81.86%

Holding current value

$17.9 Million

Previous $69.7 Million 80.7%

% of portfolio

0.02%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $51.2 Million - $63.8 Million	-1,000,874 Reduced 81.86%	221,755 $13.4 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $15 Million - $17.6 Million	264,455 Added 27.6%	1,222,629 $69.7 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $6.75 Million - $8.31 Million	-129,437 Reduced 11.9%	958,174 $60.2 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $25.6 Million - $29.2 Million	442,853 Added 68.69%	1,087,611 $62.8 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $801,004 - $992,352	13,142 Added 2.08%	644,758 $40.1 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $19.5 Million - $23.9 Million	277,353 Added 78.29%	631,616 $45.6 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $15.7 Million - $19.7 Million	-233,711 Reduced 39.75%	354,263 $28.5 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $34 Million - $42.5 Million	513,224 Added 686.59%	587,974 $39.2 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $4.95 Million - $6.22 Million	74,750 New	74,750 $5.68 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $2.42 Million - $2.97 Million	-35,297 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $2.82 Million - $3.09 Million	35,297 New	35,297 $2.97 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $1.47 Million - $1.78 Million	-18,210 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $1.12 Million - $1.44 Million	13,132 Added 258.61%	18,210 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $376,686 - $553,146	5,078 New	5,078 $528,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $6.15 Million - $8.36 Million	-97,279 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $7.11 Million - $9.31 Million	97,279 New	97,279 $8.49 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $627,489 - $745,542	-8,617 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$73.52 - $88.7 $526,844 - $635,624	-7,166 Reduced 45.4%	8,617 $732,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1 Million - $1.39 Million	15,783 New	15,783 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $231,426 - $276,682	-3,956 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $95,527 - $114,833	1,547 Added 64.22%	3,956 $273,000
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $146,587 - $202,307	2,409 New	2,409 $161,000

Others Institutions Holding INCY

# of Institutions

635

Shares Held

193M

Call Options Held

763K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Incyte Corp Transaction History